Opus Genetics IRD Issuance of Series B preferred stock, (in shares)
Other financials
Where this comes from
Reported directly by Opus Genetics in its filing.
Tagged under the XBRL concept ird:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues.
The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Opus Genetics's issuance of series b preferred stock, (in shares).
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Opus Genetics's issuance of series b preferred stock, (in shares)?
- Opus Genetics (IRD) reported issuance of series b preferred stock, (in shares) of 7.4M in Q1 2026.